Steven D. Rubin, Executive VP-Administration, Director at Opko Health, holds 15.00K shares in Entera Bio (Ticker: ENTX), holds 145.59K shares in Red Violet (Ticker: RDVT), holds 15.75K shares in Eloxx Pharmaceuticals (Ticker: ELOX). Most recently, Steven D. Rubin Bought ― shares of Entera Bio on Feb 17, 2026 for an estimated value of $7.45K.
What is the percentage of profitable transactions made by Steven D. Rubin?
The percentage of profitable transactions made by Steven D. Rubin is 29%.
What is the average return per transaction made by Steven D. Rubin?
The average return per transaction made by Steven D. Rubin is 7.70%.
What stocks does Steven D. Rubin hold?
Steven D. Rubin holds: OPK, NAGE, COCP, RDVT, ENTX, FLNT, ROX, ELOX, PBTH stocks.
What was Steven D. Rubin’s latest transaction?
Steven D. Rubin latest transaction was an Informative Buy of $7.45K.
What was Steven D. Rubin's most profitable transaction?
Steven D. Rubin’s most profitable transaction was an Informative Buy of OPK stock on October 25, 2019. The return on the trade was 198.60%.
What is Steven D. Rubin's role in Opko Health?
Steven D. Rubin's role in Opko Health is Executive VP-Administration, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.